The effect of beta-adrenergic receptor blocking agents on drug-induced insulin secretion.
D000262:Adenylyl Cyclases / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac; D003920:Diabetes Mellitus / Q000139:chemically induced; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D051379:Mice; D009711:Nucleotides / Q000378:metabolism; D014044:Tolbutamide / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D007328:Insulin; D009711:Nucleotides; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D014044:Tolbutamide; D000262:Adenylyl Cyclases; D005947:Glucose